ORCHARD THERAPEUTICS PLC Finite-Lived Intangible Asset, Expected Amortization, Year Two
ORCHARD THERAPEUTICS PLC had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $347.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2023-11-13
- 2023-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $347.00K.
- 2023-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $342.00K.
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $342.00K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $343.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Two |
|---|---|
| 2023-09-30 | $347.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $342.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $342.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $343.00K 10-K · filed 2023-03-14 |
| 2022-09-30 | $348.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $354.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $360.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $364.00K 10-K · filed 2022-03-30 |
| 2021-09-30 | $410.00K 10-Q · filed 2021-11-04 |